Sales decline 15.75% to Rs 175.18 crore
Net profit of Caplin Point Laboratories declined 2.98% to Rs 102.59 crore in the quarter ended September 2025 as against Rs 105.74 crore during the previous quarter ended September 2024. Sales declined 15.75% to Rs 175.18 crore in the quarter ended September 2025 as against Rs 207.93 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales175.18207.93 -16 OPM %43.3047.21 -PBDT135.02141.15 -4 PBT129.00134.66 -4 NP102.59105.74 -3Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content


